ArticleEClinicalMedicine2025
Development and validation of a multi-modal MRI-based deep learning framework for differentiation of intraspinal tumors (ISMF-Net).
Article in EClinicalMedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Clinical applications of MRI-based artificial intelligence in spinal metastases: A systematic review.Journal of bone oncology · 2026Review
- MMHC-OCPR: Prediction of Platinum Response and Recurrence Risk in Ovarian Cancer with Multimodal Deep Learning.Biomedicines · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Intraspinal tumors (ISTs) pose diagnostic challenges due to their complex anatomy and reliance on subjective clinical imaging interpretation, while artificial intelligence-based methods offer significant potential for non-invasive ISTs diagnosis. We aimed to develop and validate an MRI-based deep learning model for IST differentiation. Methods: We conducted a retrospective study across three hospitals in China between January 2010 and July 2025. This retrospective study included 1004 patients diagnosed with ISTs, categorized into Schwannoma (SCN), Meningioma (MNG), Astrocytoma (AST), Ependymoma (EPN), and Metastasis (MET). Patients from Center 1 (n = 723) formed the internal dataset, which was randomly divided into training, validation and internal test sets at a 7:1:2 ratio. Additionally, 281 patients from Centers 2 and 3 were used as an external test set. All patients underwent preoperative spinal MRI, including sagittal T1-weighted (T1W), T2-weighted (T2W), T2 fat-suppressed (T2FS) and axial T2W sequences. We proposed the ISMF-Net that integrates features from sequences and clinical data to differentiate ISTs. Diagnostic improvements with model assistance were evaluated through an observer study involving radiologists of different levels of experience. Findings: Among 1004 patients, 22.6% had SCN, 21.8% had MNG, 14.9% had AST, 18.2% had EPN, and 22.5% had MET. The proposed ISMF-Net achieved micro-ACC of 0.859 [0.827, 0.889], 0.849 [0.826, 0.874], and 0.821 [0.801, 0.841] on the validation, internal test, and external test sets, respectively, outperforming existing methods. The highest performance was observed for SCN (F1: 0.905 [0.879, 0.930]-0.940 [0.910, 0.968]), while MET showed lower performance (F1: 0.757 [0.724, 0.790]-0.804 [0.746, 0.858]). Model assistance significantly improved diagnostic performance across all radiologists, with junior radiologists benefiting the most, showing increases of 7.9%, 20.1% and 4.9% in accuracy, sensitivity, and specificity, respectively. Additionally, preference analysis confirmed strong alignment between the model's predictions and radiologists' diagnostic tendencies. Interpretation: This study proposes a multi-modal DL approach integrating MRI and clinical data to improve IST diagnosis, providing a valuable tool for enhancing diagnostic accuracy in clinical practice. Funding: This study was funded by the General Program from Department of Education of Liaoning Province (JYTMS20230132), the National Natural Science Foundation of China (82304235) and the China Postdoctoral Science Foundation (2024M753641).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.